Download File - JOHN J. HADDAD, Ph.D.

48 Levey
27. Di Paolo NC, Tuve S, Ni S, et al. Effect of adenovirus-mediated heat shock protein
expression and oncolysis in combination with low-dose cyclophosphamide treatment
on antitumor immune responses. Cancer Res 2006; 66(2):960–969.
28. Liu S, Wang H, Yang Z, et al. Enhancement of cancer radiation therapy by use of
adenovirus-mediated secretable glucose-regulated protein 94/gp96 expression.
Cancer Res 2005; 65(20):9126–9131.
29. Popovic D, El-Shami KM, Vadai E, et al. Antimetastatic vaccination against Lewis
lung carcinoma with autologous tumor cells modified to express murine interleukin
12. Clin Exp Metastasis 1998; 16(7):623–632.
30. el-Shami KM, Tzehoval E, Vadai E, et al. Induction of antitumor immunity with
modified autologous cells expressing membrane-bound murine cytokines. J Interferon
Cytokine Res 1999; 19(12):1391–1401.
31. Porgador A, Bannerji R, Watanabe Y, et al. Antimetastatic vaccination of tumorbearing
mice with two types of IFN-gamma gene-inserted tumor cells. J Immunol
1993; 150(4):1458–1470.
32. Porgador A, Gansbacher B, Bannerji R, et al. Anti-metastatic vaccination of tumorbearing
mice with IL-2-gene-inserted tumor cells. Int J Cancer 1993; 53(3):471–477.
33. Porgador A, Tzehoval E, Katz A, et al. Interleukin 6 gene transfection into Lewis
lung carcinoma tumor cells suppresses the malignant phenotype and confers
immunotherapeutic competence against parental metastatic cells. Cancer Res 1992;
52(13):3679–3686.
34. Clary BM, Coveney EC, Blazer DGIIIrd, et al. Active immunization with tumor
cells transduced by a novel AAV plasmid-based gene delivery system. J Immunother
1997; 20(1):26–37.
35. Sumimoto H, Tani K, Nakazaki Y, et al. Superiority of interleukin-12-transduced
murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic
antitumor immunity in syngeneic immunocompetent mice. Cancer Gene Ther 1998;
5(1):29–37.
36. Heike Y, Takahashi M, Ohira T, et al. Genetic immunotherapy by intrapleural,
intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma
cells. Int J Cancer 1997; 73(6):844–849.
37. Morita T, Ikeda K, Douzono M, et al. Tumor vaccination with macrophage
colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 1996;
88(3):955–961.
38. Lee CT, Wu S, Ciernik IF, et al. Genetic immunotherapy of established tumors with
adenovirus-murine granulocyte-macrophage colony-stimulating factor. Hum Gene
Ther 1997; 8(2):187–193.
39. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells
engineered to secrete murine granulocyte-macrophage colony-stimulating factor
stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad
Sci USA 1993; 90(8):3539–3543.
40. Abdel-Wahab Z, Dar MM, Hester D, et al. Effect of irradiation on cytokine production,
MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma
gene-modified melanoma cells. Cell Immunol 1996; 171(2):246–254.
41. Sampson JH, Archer GE, Ashley DM, et al. Subcutaneous vaccination with irradiated,
cytokine-producing tumor cells stimulates CD8þ cell-mediated immunity
against tumors located in the “immunologically privileged” central nervous system.
Proc Natl Acad Sci USA 1996; 93(19):10399–10404.